Medicus Sciences Acquisition Corp. financial data

Industry
Blank Checks
Location
152 West 57 Th Street, Floor 20, New York, NY
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 14, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.21K % +49.9%
Debt-to-equity -133 % -3.4%
Return On Equity -94 % -141%
Return On Assets 4.21 % +38%

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -703K USD -47.6%
Nonoperating Income (Expense) 4.64M USD -77.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 3.94M USD +82.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 977K USD -38.4%
Assets, Current 1.05M USD -41.5%
Assets 93.4M USD -0.39%
Accrued Liabilities, Current 55.4K USD
Liabilities, Current 55.4K USD -40.3%
Liabilities 3.87M USD -52.7%
Retained Earnings (Accumulated Deficit) -2.82M USD +55.7%
Stockholders' Equity Attributable to Parent -2.82M USD +55.7%
Liabilities and Equity 93.4M USD -0.39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -137K USD +66.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -137K USD -107%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 977K USD -38.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%